RIZZI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 7.196
AS - Asia 5.292
EU - Europa 4.292
SA - Sud America 624
AF - Africa 107
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.520
Nazione #
US - Stati Uniti d'America 6.947
VN - Vietnam 1.540
SG - Singapore 1.467
IT - Italia 1.369
CN - Cina 945
DE - Germania 617
HK - Hong Kong 555
RU - Federazione Russa 483
BR - Brasile 458
FR - Francia 425
IE - Irlanda 270
SE - Svezia 229
GB - Regno Unito 203
CA - Canada 199
IN - India 156
UA - Ucraina 119
FI - Finlandia 114
ID - Indonesia 112
AT - Austria 101
BD - Bangladesh 77
KR - Corea 70
NL - Olanda 66
TR - Turchia 62
PL - Polonia 57
AR - Argentina 53
IQ - Iraq 52
JP - Giappone 51
ES - Italia 47
DK - Danimarca 45
BE - Belgio 37
CH - Svizzera 35
PK - Pakistan 33
ZA - Sudafrica 33
CO - Colombia 27
MX - Messico 27
EC - Ecuador 25
PH - Filippine 22
SA - Arabia Saudita 21
VE - Venezuela 17
CL - Cile 16
UZ - Uzbekistan 13
CZ - Repubblica Ceca 12
KE - Kenya 12
MA - Marocco 12
PY - Paraguay 12
TW - Taiwan 12
NP - Nepal 11
AE - Emirati Arabi Uniti 10
MY - Malesia 10
RO - Romania 10
BG - Bulgaria 8
EG - Egitto 8
IR - Iran 8
JM - Giamaica 8
JO - Giordania 8
UY - Uruguay 8
LT - Lituania 7
TH - Thailandia 7
AZ - Azerbaigian 6
LB - Libano 6
PT - Portogallo 6
TN - Tunisia 6
CR - Costa Rica 5
EE - Estonia 5
ET - Etiopia 5
OM - Oman 5
PS - Palestinian Territory 5
RS - Serbia 5
SN - Senegal 5
AU - Australia 4
BO - Bolivia 4
DZ - Algeria 4
GR - Grecia 4
HN - Honduras 4
HR - Croazia 4
KG - Kirghizistan 4
MN - Mongolia 4
NG - Nigeria 4
PE - Perù 4
AL - Albania 3
AO - Angola 3
CY - Cipro 3
HU - Ungheria 3
KW - Kuwait 3
KZ - Kazakistan 3
LY - Libia 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
SI - Slovenia 3
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
Totale 17.503
Città #
Ann Arbor 1.418
Singapore 931
Ashburn 623
Hong Kong 541
Ho Chi Minh City 458
San Jose 440
Frankfurt am Main 404
Hanoi 374
Milan 370
Chandler 348
Wilmington 309
Fairfield 300
Woodbridge 294
Dublin 239
Beijing 209
Dallas 181
New York 176
Los Angeles 155
Santa Clara 140
Dearborn 139
Houston 138
Seattle 138
Toronto 124
Chicago 107
Jakarta 99
Cambridge 97
The Dalles 94
Hefei 92
Vienna 88
Princeton 86
Jacksonville 84
Council Bluffs 82
Rome 68
Helsinki 64
Seoul 61
Da Nang 59
Buffalo 55
Lauterbourg 54
Nanjing 54
Shanghai 50
Haiphong 48
Moscow 45
London 42
Munich 42
São Paulo 42
Tokyo 38
Boardman 36
Brussels 36
Guangzhou 35
Pune 35
Altamura 33
Biên Hòa 33
Kent 33
Orem 31
Warsaw 31
Lawrence 30
Ha Long 28
Monza 28
Nuremberg 28
Baghdad 24
Brooklyn 24
Denver 24
Can Tho 23
Fremont 23
Quận Bình Thạnh 23
Ankara 22
Hải Dương 22
Ninh Bình 22
Rio de Janeiro 21
Sligo 21
Turku 21
Bắc Ninh 20
San Diego 20
Stockholm 20
Thái Nguyên 20
Bari 19
Zurich 19
Bắc Giang 18
Hangzhou 17
Phoenix 17
Poplar 17
San Francisco 17
Turin 17
Vũng Tàu 17
Dong Ket 16
Romola 16
Shenyang 16
Andover 15
Carate Brianza 15
Kunming 15
Montreal 15
Nanchang 15
Amsterdam 14
Columbus 14
Lachine 14
Quận Một 14
Atlanta 13
Johannesburg 13
Phủ Lý 13
Tashkent 13
Totale 11.156
Nome #
Identificazione di nuove strategie terapeutiche per il controllo dell'obesità e della cachessia mediante utilizzo di nuovi composti peptidomimetici dotati di attività antagonista o agonista dell'ormone peptidico endogeno ghrelin 616
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 526
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 511
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 504
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 494
Treatment with levosimendan in an experimental model of early ventilator-induced diaphragmatic dysfunction 473
Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction 462
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 458
Growth hormone secretagogues and the regulation of calcium signaling in muscle 445
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 440
Effect of nutrition on neurodegenerative diseases. A systematic review 394
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 392
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 391
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 364
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 355
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 343
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 338
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 323
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 319
The role of nutrition on Parkinson’s disease: a systematic review 317
Neurotrophic and neuroregenerative effects of GH/IGF1 316
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 307
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 305
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 305
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 301
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 299
Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies 292
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 289
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 286
Parma consensus statement on metabolic disruptors 283
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 282
New linezolid-like 1,2,4-oxadiazolesactive against Gram-positive multiresistant pathogens 281
Characterization of synovial cytokine patterns in bucket-handle and posterior horn meniscal tears 281
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 276
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 272
TLQP-21 modulate inflammation and fibrosis in a model of ards 271
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 253
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structure 252
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 249
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 246
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 243
Androgen therapy in neurodegenerative diseases 238
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 235
Agreement and tense as distinctive syntactic positions. Evidence from acquisition 229
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 228
Prokineticin 2 and Cytokine Content in the Synovial Fluid of Knee Osteoarthritis and Traumatic Meniscal Tear Patients: Preliminary Results 223
The role of androgens in women's health and wellbeing 214
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 212
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 203
Resolvin E1 and Cytokines Environment in Skeletally Immature and Adult ACL Tears 201
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 197
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 193
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 193
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 169
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 142
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 142
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 133
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 130
Correction to: Parma consensus statement on metabolic disruptors (Environmental Health: A Global Access Science Source (2015) 14:1 (54) DOI: 10.1186/s12940-015-0042-7) 124
Extracellular matrix (ECM) and cellular features of a pediatric meniscus 117
Role of nutrition in degenerative disease 107
Anti-Inflammatory Effects of Progesterone on Human Microglia via TLR4/NLRP3 Pathway Modulation: Relevance to Drug-Resistant Epilepsy 6
Totale 17.990
Categoria #
all - tutte 51.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.870


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021155 0 0 0 0 0 0 0 0 0 0 0 155
2021/2022889 116 96 82 84 49 58 41 31 25 90 70 147
2022/20231.542 160 359 181 145 85 232 27 105 101 29 54 64
2023/20241.151 34 67 83 82 124 246 193 67 70 59 26 100
2024/20252.829 152 222 202 186 225 202 240 152 191 372 240 445
2025/20267.646 1.482 706 561 741 824 498 980 287 541 557 307 162
Totale 17.990